NCT03554265View on ClinicalTrials.gov

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

October 4, 2023

Study Completion Date

October 4, 2023

Conditions
Traumatic Brain InjuryFatigueCognitive ImpairmentCOVID-19
Interventions
DRUG

Somatropin

Genotropin given by injection

Trial Locations (1)

77555

University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT03554265 - Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy | Biotech Hunter | Biotech Hunter